AI Science Tracker
EN

Identification of Biomarkers Associated with Heart Failure Caused by Idiopathic Dilated Cardiomyopathy Using WGCNA and Machine Learning Algorithms

Department of Clinical Laboratory, Jining First People's Hospital, Jining, Shandong, China · 25 Apr 2023 · medicine

Discovery

Identification of Biomarkers Associated with Heart Failure Caused by Idiopathic Dilated Cardiomyopathy Using WGCNA and Machine Learning Algorithms

Source check: Source checked. Not independent scientific confirmation.

Finding: WGCNA, SVM-RFE and LASSO identified 13 candidate genes from idiopathic-dilated-cardiomyopathy heart-failure expression data. AQP3 and CYP2J2 showed diagnostic signal in GEO datasets GSE57338 and GSE6406, respectively; this is retrospective transcriptomic analysis, not clinical validation.

Technology: Weighted gene co-expression network analysis (WGCNA) narrowed candidate genes; SVM-RFE and LASSO selected biomarkers, then external GEO expression datasets checked AQP3 and CYP2J2.

Publication: Peer-reviewed paper · Test context: retrospective or benchmark. Catalog categories, not an evidence grade.

AI contribution
Weighted gene co-expression network analysis (WGCNA) narrowed candidate genes; SVM-RFE and LASSO selected biomarkers, then external GEO expression datasets checked AQP3 and CYP2J2.
Test and result
WGCNA, SVM-RFE and LASSO identified 13 candidate genes from idiopathic-dilated-cardiomyopathy heart-failure expression data
Limitation / still unknown
AQP3 and CYP2J2 showed diagnostic signal in GEO datasets GSE57338 and GSE6406, respectively; this is retrospective transcriptomic analysis, not clinical validation.
Evidence sources and annotation context

Evidence context (descriptions follow the cited sources; test type is a catalog classification):

Evidence sources: https://pmc.ncbi.nlm.nih.gov/articles/PMC10154102/ · https://pubmed.ncbi.nlm.nih.gov/37143707/

Source checked · editorial details

The source page was checked against this entry. Independent confirmation is not assessed by this label.

Source type: paper. Paper: linked separately.

Review date: 22 Nov 2026. Review scope: Primary result-bearing material for the stated method, result and evaluation, with bibliographic version information..

No follow-up recorded; this is not a claim that no follow-up exists. Follow-up review scope and date are not recorded. No source-supported relationships recorded.

Editorial assessment: Impact 2/5 · Validation 2/5 · Novelty 2/5. Impact and novelty are editorial judgments; validation follows the annotated test type where one exists. Not an evidence grade. Scoring criteria.

Open in the full catalog for filters, charts and related discoveries. Browse medicine discoveries.